Qian Chen
Impact in
- Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.01%
- Nanoplatforms for cancer theranostics
Papers in
- Immunology 164
- Immunotherapy and Immune Responses 54
- Immune Cell Function and Interaction 36
- Immune cells in cancer 29
- Biomaterials 69
- Nanoparticle-Based Drug Delivery 43
- Journals
- Advanced Materials (20 papers)Biomaterials (18 papers)Advanced Functional Materials (16 papers)ACS Nano (15 papers)Frontiers in Immunology (14 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Qian Chen
860 papers receiving 41.0k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Biomaterials 6.5k
- Biomedical Engineering 16.9k
- Immunology 7.9k
- Microbiology 1.9k
- Cell Biology 3.5k
Countries citing papers authored by Qian Chen
This map shows the geographic impact of Qian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Chen more than expected).
Fields of papers citing papers by Qian Chen
This network shows the impact of papers produced by Qian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Chen. The network helps show where Qian Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Qian Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 26 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 33 | |
| 11 | 2023 | 22 | |
| 12 | 2023 | 18 | |
| 13 | 2022 | 15 | |
| 14 | 2020 | 200 | |
| 15 | High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma | 2020 | 1 |
| 16 | CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway | 2019 | 1 |
| 17 | 2018 | 168 | |
| 18 | 2015 | 60 | |
| 19 | 2009 | 60 | |
| 20 | 2008 | 275 |
About Qian Chen
Qian Chen is a scholar working on Immunology, Biomaterials, Cancer Research, Oncology and Biomedical Engineering, having authored 901 papers that have together received 41.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (129 papers), Immunotherapy and Immune Responses (54 papers), Nanoparticle-Based Drug Delivery (43 papers), Cancer Immunotherapy and Biomarkers (38 papers), Immune Cell Function and Interaction (36 papers), Advanced Nanomaterials in Catalysis (33 papers), Immune cells in cancer (29 papers) and RNA Interference and Gene Delivery (28 papers). The work is most often cited by research in Biomaterials (6.5k citations), Biomedical Engineering (16.9k citations), Immunology (7.9k citations), Microbiology (1.9k citations) and Cell Biology (3.5k citations). Qian Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhuang Liu, Chao Wang, Chao Liang, Ligeng Xu, Liangzhu Feng, De Yang, Joost J. Oppenheim, Ziliang Dong, Rui Peng and Liang Cheng. Their work appears in journals such as Advanced Materials, Biomaterials, Advanced Functional Materials, ACS Nano and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.